Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer

doi:10.3748/wjg.v22.i28.6345

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16898)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

1223

WORD

434

HTML

10854

Figures (1-2)

573

Tables (1-1)

291

Sum=13375

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

367

Download

465

Sum=832

Publishing Process of This Article

Item

Count

Browse

1162

Download

1529

Sum=2691

Jul 28, 2016 (publication date) through Dec 30, 2024

Times Cited of This Article

Times Cited (94)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jul 28, 2016; 22(28): 6345-6361
Published online Jul 28, 2016. doi: 10.3748/wjg.v22.i28.6345

Full Size Figure Download Figure

Figure 1 Epidermal growth factor receptor and its downstream signaling pathway. Binding of ligands such as epidermal growth factor (EGF) to Epidermal growth factor receptor (EGFR) activates downstream Ras/ERK and PI3K/Akt pathways and regulates various physiological processes. The anti-EGFR monoclonal antibodies (mAbs) cetuximab and panitumumab block the activation of these pathways.

Citation: Sforza V, Martinelli E, Ciardiello F, Gambardella V, Napolitano S, Martini G, della Corte C, Cardone C, Ferrara ML, Reginelli A, Liguori G, Belli G, Troiani T. Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer. World J Gastroenterol 2016; 22(28): 6345-6361
URL: https://www.wjgnet.com/1007-9327/full/v22/i28/6345.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i28.6345